Catalyst Wire Dossier Catalyst Wire Dossier

SDMB (2,2-dimethylbutyrate, sodium salt)

2,2-dimethylbutyrate sodium salt
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SDMB (2,2-dimethylbutyrate, sodium salt), covering 2013-03-13 to 2013-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of SDMB (2,2 Dimethylbutyrate, Sodium Salt) in Beta Thalassemia Intermedia in Thailand [Phase 2]

See pricing